Amicus Therapeutics (FOLD)

Amicus (FOLD) Stock Price & Analysis


FOLD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.50 - $13.84
Previous Close$11.11
Average Volume (3M)2.47M
Market Cap
Enterprise Value$3.35B
Total Cash (Recent Filing)$267.11M
Total Debt (Recent Filing)$452.01M
Price to Earnings (P/E)-15.7
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding284,575,686
10 Day Avg. Volume3,267,463
30 Day Avg. Volume2,469,217
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)-34.09
Price to Sales (P/S)36.65
Price to Cash Flow (P/CF)-10.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.94
Enterprise Value/Gross Profit11.51
Enterprise Value/Ebitda-19.18
Price Target Upside32.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Amicus Therapeutics’s price range in the past 12 months?
Amicus Therapeutics lowest stock price was $7.50 and its highest was $13.84 in the past 12 months.
    What is Amicus Therapeutics’s market cap?
    Currently, no data Available
    When is Amicus Therapeutics’s upcoming earnings report date?
    Amicus Therapeutics’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
      How were Amicus Therapeutics’s earnings last quarter?
      Amicus Therapeutics released its earnings results on May 10, 2023. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.138 by -$0.042.
        Is Amicus Therapeutics overvalued?
        According to Wall Street analysts Amicus Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Amicus Therapeutics pay dividends?
          Amicus Therapeutics does not currently pay dividends.
          What is Amicus Therapeutics’s EPS estimate?
          Amicus Therapeutics’s EPS estimate is -$0.12.
            How many shares outstanding does Amicus Therapeutics have?
            Amicus Therapeutics has 284,575,680 shares outstanding.
              What happened to Amicus Therapeutics’s price movement after its last earnings report?
              Amicus Therapeutics reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.138. Following the earnings report the stock price went down -5.004%.
                Which hedge fund is a major shareholder of Amicus Therapeutics?
                Among the largest hedge funds holding Amicus Therapeutics’s share is Perceptive Advisors LLC. It holds Amicus Therapeutics’s shares valued at 307M.


                  Amicus Stock Smart Score

                  The Amicus stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Amicus Therapeutics

                  Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.


                  Top 5 ETFs holding FOLD

                  Market Value
                  Smart Score
                  iShares Biotechnology ETF
                  Vanguard Health Care ETF
                  Invesco DWA Healthcare Momentum ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold FOLD. The ETFs are listed according to market value of FOLD within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Intellia Therapeutics
                  Vir Biotechnology
                  Arrowhead Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis